MEEDER ASSET MANAGEMENT INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2021$0
-100.0%
190.0%0.00%
Q2 2021$1,0000.0%190.0%0.00%
Q1 2021$1,0000.0%190.0%0.00%
Q4 2020$1,0000.0%190.0%0.00%
Q3 2020$1,000
-50.0%
19
-52.5%
0.00%
Q1 2020$2,000
-50.0%
40
-16.7%
0.00%
Q4 2019$4,000
+100.0%
48
+20.0%
0.00%
Q3 2019$2,0000.0%400.0%0.00%
Q2 2019$2,0000.0%400.0%0.00%
Q1 2019$2,000
-84.6%
40
-87.3%
0.00%
-100.0%
Q4 2018$13,000
-99.8%
315
+129.9%
0.00%0.0%
Q2 2018$6,193,000
+19253.1%
137
-79.0%
0.00%
-66.7%
Q1 2018$32,000
+700.0%
653
+573.2%
0.00%
Q4 2017$4,000
+100.0%
97
+59.0%
0.00%
Q3 2017$2,000
-66.7%
61
-70.2%
0.00%
-100.0%
Q2 2017$6,000
+20.0%
205
+40.4%
0.00%
Q1 2017$5,000
-44.4%
146
-77.0%
0.00%
-100.0%
Q4 2016$9,0006360.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders